Literature DB >> 31493035

Unexplained exertional intolerance associated with impaired systemic oxygen extraction.

Kathryn H Melamed1, Mário Santos2,3, Rudolf K F Oliveira4, Mariana Faria Urbina2,3, Donna Felsenstein5, Alexander R Opotowsky6,3, Aaron B Waxman2, David M Systrom2,3.   

Abstract

PURPOSE: The clinical investigation of exertional intolerance generally focuses on cardiopulmonary diseases, while peripheral factors are often overlooked. We hypothesize that a subset of patients exists whose predominant exercise limitation is due to abnormal systemic oxygen extraction (SOE).
METHODS: We reviewed invasive cardiopulmonary exercise test (iCPET) results of 313 consecutive patients presenting with unexplained exertional intolerance. An exercise limit due to poor SOE was defined as peak exercise (Ca-vO2)/[Hb] ≤ 0.8 and VO2max < 80% predicted in the absence of a cardiac or pulmonary mechanical limit. Those with peak (Ca-vO2)/[Hb] > 0.8, VO2max ≥ 80%, and no cardiac or pulmonary limit were considered otherwise normal. The otherwise normal group was divided into hyperventilators (HV) and normals (NL). Hyperventilation was defined as peak PaCO2 < [1.5 × HCO3 + 6].
RESULTS: Prevalence of impaired SOE as the sole cause of exertional intolerance was 12.5% (32/257). At peak exercise, poor SOE and HV had less acidemic arterial blood compared to NL (pHa = 7.39 ± 0.05 vs. 7.38 ± 0.05 vs. 7.32 ± 0.02, p < 0.001), which was explained by relative hypocapnia (PaCO2 = 29.9 ± 5.4 mmHg vs. 31.6 ± 5.4 vs. 37.5 ± 3.4, p < 0.001). For a subset of poor SOE, this relative alkalemia, also seen in mixed venous blood, was associated with a normal PvO2 nadir (28 ± 2 mmHg vs. 26 ± 4, p = 0.627) but increased SvO2 at peak exercise (44.1 ± 5.2% vs. 31.4 ± 7.0, p < 0.001).
CONCLUSIONS: We identified a cohort of patients whose exercise limitation is due only to systemic oxygen extraction, due to either an intrinsic abnormality of skeletal muscle mitochondrion, limb muscle microcirculatory dysregulation, or hyperventilation and left shift the oxyhemoglobin dissociation curve.

Entities:  

Keywords:  Cardiopulmonary exercise testing; Chronic fatigue syndrome; Exertional intolerance; Hyperventilation; Poor systemic oxygen extraction

Mesh:

Year:  2019        PMID: 31493035     DOI: 10.1007/s00421-019-04222-6

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  59 in total

1.  The exercise metaboreflex is maintained in the absence of muscle acidosis: insights from muscle microdialysis in humans with McArdle's disease.

Authors:  J Vissing; D A MacLean; S F Vissing; M Sander; B Saltin; R G Haller
Journal:  J Physiol       Date:  2001-12-01       Impact factor: 5.182

2.  Pooling in chronic orthostatic intolerance: arterial vasoconstrictive but not venous compliance defects.

Authors:  Julian M Stewart
Journal:  Circulation       Date:  2002-05-14       Impact factor: 29.690

3.  Diaphragm arterioles are less responsive to alpha1- adrenergic constriction than gastrocnemius arterioles.

Authors:  Aaron Aaker; M H Laughlin
Journal:  J Appl Physiol (1985)       Date:  2002-05

4.  The epidemiology of pathogenic mitochondrial DNA mutations.

Authors:  P F Chinnery; M A Johnson; T M Wardell; R Singh-Kler; C Hayes; D T Brown; R W Taylor; L A Bindoff; D M Turnbull
Journal:  Ann Neurol       Date:  2000-08       Impact factor: 10.422

5.  A forearm exercise screening test for mitochondrial myopathy.

Authors:  Tina D Jensen; Pedram Kazemi-Esfarjani; Elwira Skomorowska; John Vissing
Journal:  Neurology       Date:  2002-05-28       Impact factor: 9.910

6.  Venous oxygen levels during aerobic forearm exercise: An index of impaired oxidative metabolism in mitochondrial myopathy.

Authors:  Tanja Taivassalo; Amy Abbott; Phil Wyrick; Ronald G Haller
Journal:  Ann Neurol       Date:  2002-01       Impact factor: 10.422

7.  Impeding O(2) unloading in muscle delays oxygen uptake response to exercise onset in humans.

Authors:  N Hayashi; M Ishihara; A Tanaka; T Yoshida
Journal:  Am J Physiol       Date:  1999-11

8.  Unexplained exertional limitation: characterization of patients with a mitochondrial myopathy.

Authors:  K R Flaherty; J Wald; I M Weisman; R J Zeballos; M A Schork; M Blaivas; M Rubenfire; F J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2001-08-01       Impact factor: 21.405

9.  Temperature of mixed venous blood during exercise.

Authors:  T Brundin
Journal:  Scand J Clin Lab Invest       Date:  1975-10       Impact factor: 1.713

10.  The spectrum of exercise tolerance in mitochondrial myopathies: a study of 40 patients.

Authors:  Tanja Taivassalo; Tina Dysgaard Jensen; Nancy Kennaway; Salvatore DiMauro; John Vissing; Ronald G Haller
Journal:  Brain       Date:  2003-02       Impact factor: 13.501

View more
  10 in total

Review 1.  Performance and Interpretation of Invasive Hemodynamic Exercise Testing.

Authors:  C Charles Jain; Barry A Borlaug
Journal:  Chest       Date:  2020-05-28       Impact factor: 9.410

Review 2.  [Post-COVID syndrome with fatigue and exercise intolerance: myalgic encephalomyelitis/chronic fatigue syndrome].

Authors:  Herbert Renz-Polster; Carmen Scheibenbogen
Journal:  Inn Med (Heidelb)       Date:  2022-07-13

3.  The Pathobiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Case for Neuroglial Failure.

Authors:  Herbert Renz-Polster; Marie-Eve Tremblay; Dorothee Bienzle; Joachim E Fischer
Journal:  Front Cell Neurosci       Date:  2022-05-09       Impact factor: 6.147

4.  Age-Related Changes in the Thermoregulatory Properties in Bank Voles From a Selection Experiment.

Authors:  Marta Grosiak; Paweł Koteja; Ulf Bauchinger; Edyta T Sadowska
Journal:  Front Physiol       Date:  2020-11-19       Impact factor: 4.566

5.  Diagnostic utility of sub-maximum cardiopulmonary exercise testing in the ambulatory setting for heart failure with preserved ejection fraction.

Authors:  Hannah T Oakland; Phillip Joseph; Ahmed Elassal; Marjorie Cullinan; Paul M Heerdt; Inderjit Singh
Journal:  Pulm Circ       Date:  2020-11-25       Impact factor: 3.017

6.  Cardiopulmonary, metabolic, and perceptual responses during exercise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Multi-site Clinical Assessment of ME/CFS (MCAM) sub-study.

Authors:  Dane B Cook; Stephanie VanRiper; Ryan J Dougherty; Jacob B Lindheimer; Michael J Falvo; Yang Chen; Jin-Mann S Lin; Elizabeth R Unger
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.240

Review 7.  Exercise metabolomics in pulmonary arterial hypertension: Where pulmonary vascular metabolism meets exercise physiology.

Authors:  Michael H Lee; Thaís C F Menezes; Julie A Reisz; Eloara V M Ferreira; Brian B Graham; Rudolf K F Oliveira
Journal:  Front Physiol       Date:  2022-09-12       Impact factor: 4.755

8.  Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study.

Authors:  Ingrid G Rekeland; Alexander Fosså; Asgeir Lande; Irini Ktoridou-Valen; Kari Sørland; Mari Holsen; Karl J Tronstad; Kristin Risa; Kine Alme; Marte K Viken; Benedicte A Lie; Olav Dahl; Olav Mella; Øystein Fluge
Journal:  Front Med (Lausanne)       Date:  2020-04-29

9.  Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients.

Authors:  Jihyun Lee; Suzanne D Vernon; Patricia Jeys; Weam Ali; Andrea Campos; Derya Unutmaz; Brayden Yellman; Lucinda Bateman
Journal:  J Transl Med       Date:  2020-08-15       Impact factor: 5.531

10.  A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome.

Authors:  Fredrik Hoel; August Hoel; Ina Kn Pettersen; Ingrid G Rekeland; Kristin Risa; Kine Alme; Kari Sørland; Alexander Fosså; Katarina Lien; Ingrid Herder; Hanne L Thürmer; Merete E Gotaas; Christoph Schäfer; Rolf K Berge; Kristian Sommerfelt; Hans-Peter Marti; Olav Dahl; Olav Mella; Øystein Fluge; Karl J Tronstad
Journal:  JCI Insight       Date:  2021-08-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.